Report Detail
Global Oligonucleotide Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4619790 |
- 26 September, 2024 |
- Global |
- 95 Pages |
- GIR (Global Info Research) |
- Other
Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
According to our (Global Info Research) latest study, the global Oligonucleotide Therapeutics market size was valued at US$ 4470 million in 2023 and is forecast to a readjusted size of USD 12730 million by 2030 with a CAGR of 16.3% during review period.
Biogen is the industry"s biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.
This report is a detailed and comprehensive analysis for global Oligonucleotide Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Oligonucleotide Therapeutics market size and forecasts, in consumption value ($ Million), 2019-2030
Global Oligonucleotide Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Oligonucleotide Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Oligonucleotide Therapeutics market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oligonucleotide Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oligonucleotide Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Bausch & Lomb, Alnylam Pharmaceuticals, Dynavax Technologies, Kastle therapeutics, Akcea Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oligonucleotide Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Oligonucleotide Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antisense Oligonucleotide
Aptamer
Other
Market segment by Application
Neuromuscular Diseases
ATTR
Hepatic VOD
Other
Market segment by players, this report covers
Biogen
Sarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oligonucleotide Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oligonucleotide Therapeutics, with revenue, gross margin, and global market share of Oligonucleotide Therapeutics from 2019 to 2024.
Chapter 3, the Oligonucleotide Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Oligonucleotide Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oligonucleotide Therapeutics.
Chapter 13, to describe Oligonucleotide Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Oligonucleotide Therapeutics by Type
- 1.3.1 Overview: Global Oligonucleotide Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Oligonucleotide Therapeutics Consumption Value Market Share by Type in 2023
- 1.3.3 Antisense Oligonucleotide
- 1.3.4 Aptamer
- 1.3.5 Other
- 1.4 Global Oligonucleotide Therapeutics Market by Application
- 1.4.1 Overview: Global Oligonucleotide Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Neuromuscular Diseases
- 1.4.3 ATTR
- 1.4.4 Hepatic VOD
- 1.4.5 Other
- 1.5 Global Oligonucleotide Therapeutics Market Size & Forecast
- 1.6 Global Oligonucleotide Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Oligonucleotide Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Oligonucleotide Therapeutics Market Size by Region, (2019-2030)
- 1.6.3 North America Oligonucleotide Therapeutics Market Size and Prospect (2019-2030)
- 1.6.4 Europe Oligonucleotide Therapeutics Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Oligonucleotide Therapeutics Market Size and Prospect (2019-2030)
- 1.6.6 South America Oligonucleotide Therapeutics Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Oligonucleotide Therapeutics Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Biogen
- 2.1.1 Biogen Details
- 2.1.2 Biogen Major Business
- 2.1.3 Biogen Oligonucleotide Therapeutics Product and Solutions
- 2.1.4 Biogen Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Biogen Recent Developments and Future Plans
- 2.2 Sarepta Therapeutics
- 2.2.1 Sarepta Therapeutics Details
- 2.2.2 Sarepta Therapeutics Major Business
- 2.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Product and Solutions
- 2.2.4 Sarepta Therapeutics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
- 2.3 Jazz Pharmaceuticals
- 2.3.1 Jazz Pharmaceuticals Details
- 2.3.2 Jazz Pharmaceuticals Major Business
- 2.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Product and Solutions
- 2.3.4 Jazz Pharmaceuticals Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Jazz Pharmaceuticals Recent Developments and Future Plans
- 2.4 Bausch & Lomb
- 2.4.1 Bausch & Lomb Details
- 2.4.2 Bausch & Lomb Major Business
- 2.4.3 Bausch & Lomb Oligonucleotide Therapeutics Product and Solutions
- 2.4.4 Bausch & Lomb Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Bausch & Lomb Recent Developments and Future Plans
- 2.5 Alnylam Pharmaceuticals
- 2.5.1 Alnylam Pharmaceuticals Details
- 2.5.2 Alnylam Pharmaceuticals Major Business
- 2.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Product and Solutions
- 2.5.4 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
- 2.6 Dynavax Technologies
- 2.6.1 Dynavax Technologies Details
- 2.6.2 Dynavax Technologies Major Business
- 2.6.3 Dynavax Technologies Oligonucleotide Therapeutics Product and Solutions
- 2.6.4 Dynavax Technologies Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Dynavax Technologies Recent Developments and Future Plans
- 2.7 Kastle therapeutics
- 2.7.1 Kastle therapeutics Details
- 2.7.2 Kastle therapeutics Major Business
- 2.7.3 Kastle therapeutics Oligonucleotide Therapeutics Product and Solutions
- 2.7.4 Kastle therapeutics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Kastle therapeutics Recent Developments and Future Plans
- 2.8 Akcea Therapeutics
- 2.8.1 Akcea Therapeutics Details
- 2.8.2 Akcea Therapeutics Major Business
- 2.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Product and Solutions
- 2.8.4 Akcea Therapeutics Oligonucleotide Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Akcea Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Oligonucleotide Therapeutics Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Oligonucleotide Therapeutics by Company Revenue
- 3.2.2 Top 3 Oligonucleotide Therapeutics Players Market Share in 2023
- 3.2.3 Top 6 Oligonucleotide Therapeutics Players Market Share in 2023
- 3.3 Oligonucleotide Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Oligonucleotide Therapeutics Market: Region Footprint
- 3.3.2 Oligonucleotide Therapeutics Market: Company Product Type Footprint
- 3.3.3 Oligonucleotide Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Oligonucleotide Therapeutics Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Oligonucleotide Therapeutics Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Oligonucleotide Therapeutics Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Oligonucleotide Therapeutics Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Oligonucleotide Therapeutics Consumption Value by Type (2019-2030)
- 6.2 North America Oligonucleotide Therapeutics Market Size by Application (2019-2030)
- 6.3 North America Oligonucleotide Therapeutics Market Size by Country
- 6.3.1 North America Oligonucleotide Therapeutics Consumption Value by Country (2019-2030)
- 6.3.2 United States Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 6.3.3 Canada Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Oligonucleotide Therapeutics Consumption Value by Type (2019-2030)
- 7.2 Europe Oligonucleotide Therapeutics Consumption Value by Application (2019-2030)
- 7.3 Europe Oligonucleotide Therapeutics Market Size by Country
- 7.3.1 Europe Oligonucleotide Therapeutics Consumption Value by Country (2019-2030)
- 7.3.2 Germany Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 7.3.3 France Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 7.3.5 Russia Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 7.3.6 Italy Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Oligonucleotide Therapeutics Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Oligonucleotide Therapeutics Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Oligonucleotide Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Oligonucleotide Therapeutics Consumption Value by Region (2019-2030)
- 8.3.2 China Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 8.3.3 Japan Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 8.3.5 India Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 8.3.7 Australia Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Oligonucleotide Therapeutics Consumption Value by Type (2019-2030)
- 9.2 South America Oligonucleotide Therapeutics Consumption Value by Application (2019-2030)
- 9.3 South America Oligonucleotide Therapeutics Market Size by Country
- 9.3.1 South America Oligonucleotide Therapeutics Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Oligonucleotide Therapeutics Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Oligonucleotide Therapeutics Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Oligonucleotide Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Oligonucleotide Therapeutics Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
- 10.3.4 UAE Oligonucleotide Therapeutics Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Oligonucleotide Therapeutics Market Drivers
- 11.2 Oligonucleotide Therapeutics Market Restraints
- 11.3 Oligonucleotide Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Oligonucleotide Therapeutics Industry Chain
- 12.2 Oligonucleotide Therapeutics Upstream Analysis
- 12.3 Oligonucleotide Therapeutics Midstream Analysis
- 12.4 Oligonucleotide Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Oligonucleotide Therapeutics. Industry analysis & Market Report on Oligonucleotide Therapeutics is a syndicated market report, published as Global Oligonucleotide Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Oligonucleotide Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
